Medical Patent News

RSS

Lifeblood Medical receives U.S. patent notice

Lifeblood Medical has announced that it has received a Notice of Allowance from the U.S. Patent Office for its patent application titled, "Composition for Maintaining Organ and Cell Viability."

28 Mar 2007

Microbix granted Canadian patent for vaccine technology

Microbix Biosystems has announced that it has been granted a patent by the Canadian Patent Office for its Vaccine Technology. This technology holds the promise of significantly boosting global production of influenza vaccines.

22 Mar 2007

Penwest confirms action on Oxymorphone patent application

Penwest Pharmaceuticals has confirmed that the U.S. Patent and Trademark Office (PTO) has posted on its website an indication that a final rejection of Penwest's patent application claiming the sustained release formulations of Oxymorphone will be mailed.

15 Mar 2007

Court rules on remaining motions in IRIDEX patent case

IRIDEX Corporation announced today that the Hon. Catherine Perry, United States District Judge, has now ruled on all outstanding summary motions in its patent infringement suit against Synergetics USA, Inc.

13 Mar 2007

Synergetics USA updates shareholders on Iridex patent case

Synergetics USA has announced the following update to its shareholders on the status of the pending Iridex patent infringement lawsuit.

12 Mar 2007

European patent on stem cells may be a possibility

As long as the research meets the usual requirements for a patent, isolated embryonic stem cells should be considered for both method and product patents.

11 Mar 2007

Avicena issued U.S. creatine patent

Avicena Group has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,186,754, entitled, "Use of Creatine or Creatine Compounds for Skin Preservation," on March 6, 2007.

8 Mar 2007

Archemix granted two European patents

Archemix has announced today the issuance of two key, broad patents by the European Patent Office ("EPO"). The patents, EP 0 786 469 and EP 0 668 931, broadly cover methods for the identification and use of aptamers for therapeutic applications.

8 Mar 2007

ARIUS Research granted two new U.S. patents for antibodies

ARIUS Research has announced that it has been granted two new United States patents for antibodies within their CD63 program. Patent 7,175,846. covers anti-cancer antibodies in ARIUS' partnered program for melanoma, breast and prostate cancers and protects the valuable site on the disease target that the drug candidate binds to.

8 Mar 2007

Novartis to continue Indian patent fight

Novartis CEO Daniel Vasella on Tuesday at the company's annual general meeting said that the drug maker plans to continue a lawsuit challenging a section of India's Patents Act that aims to restrict certain kinds of patents, despite criticism from some HIV/AIDS advocacy groups and shareholders, Reuters reports

8 Mar 2007

Bold proposal to restructure drug development patents

Weill Cornell Medical College scientist Dr. Carl Nathan has issued a bold call for reforming the pharmaceutical development and patent systems in order to increase the number of vaccines and drugs available to combat neglected diseases that are ravaging the world's poor.

8 Mar 2007

QLT settles Massachusetts Eye and Ear Infirmary patent lawsuit

QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").

5 Mar 2007

IntraLase settles patent litigation with Escalon Medical

IntraLase Corp. has announced that it has entered into an agreement with Escalon Medical Corp. to settle all outstanding disputes and litigation between the parties.

28 Feb 2007

Court rules Synergetics product infringes IRIDEX patent

IRIDEX Corporation has announced that the Hon. Catherine Perry, United States District Judge, granted summary judgment to IRIDEX on its claim that Synergetics, Inc.'s adapter-based connector systems infringe 12 separate claims of IRIDEX's Patent No. 5,085,492.

27 Feb 2007

Pfizer wins Norvasc patent challenge by Mylan

Pfizer said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the company's U.S. patent covering the active ingredient in Norvasc

27 Feb 2007

SpectraScience granted European patent

SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."

27 Feb 2007

Spectranetics announces unfavorable jury verdict in a patent litigation dispute

Spectranetics Corporation has announced that it has received an unfavorable jury verdict in a patent litigation dispute with Dr. Peter Rentrop in the U.S. District Court in the Southern District of New York. Spectranetics has filed several post-trial motions seeking to overturn the verdict.

21 Feb 2007

Clarient receives patent for "automated detection of objects in a biological sample"

Clarient, Inc. has announced that it has been granted a new U.S. patent related to the detection and quantification of rare tumor cells in blood and bone marrow.

21 Feb 2007

Provectus receives notice of allowance for acne product

Provectus Pharmaceuticals, Inc. announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application covering novel acne medications, including the Company's invisible, solid acne treatment, Pure-Stick, which is an over- the-counter (OTC) product.

21 Feb 2007